The global complete nutrition products market size accounted for USD 5.55 billion in 2024, grew to USD 5.55 billion in 2025 and is projected to surpass around USD 10.31 billion by 2034, representing a healthy CAGR of 6.38% between 2024 and 2034. The North America complete nutrition products market size is calculated at USD 2.39 billion in 2024 and is expected to grow at a fastest CAGR of 6.50% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Complete Nutrition Products Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Complete Nutrition Products Market Revenue and Volume, by Product, 2024-2034
8.1.1. Powder
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. RTD Shakes
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Bars
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Complete Nutrition Products Market Revenue and Volume, by Distribution Channel, 2024-2034
9.1.1. Supermarket
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Convenient Stores
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Online Store
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Others
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.1.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.1.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.1.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.2.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.2.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.2.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.2.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.2.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.3.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.3.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.3.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.3.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.4.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.4.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.4.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.4.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.5.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)
10.5.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)
11.1. Abbott Laboratories
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Amway
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Danone
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Herbalife Nutrition
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Ideal Shape
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Slim Fast
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Lady Boss
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. RSP Nutrition
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Jimmy Joy
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Soylent
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample